Skip to main content

RETRACTION article

Front. Physiol., 04 August 2022
Sec. Integrative Physiology
Volume 13 - 2022 | https://doi.org/10.3389/fphys.2022.1006583
This article is part of the Research Topic Role of Mitochondria-Endoplasmic Reticulum Contacts in Cardiovascular Disorders View all 11 articles

Retraction: Mitofusin-2 enhances mitochondrial contact with the endoplasmic reticulum and promotes diabetic cardiomyopathy

This article is a retraction of:

  1. RETRACTED: Mitofusin-2 Enhances Mitochondrial Contact With the Endoplasmic Reticulum and Promotes Diabetic Cardiomyopathy

    1. Read original article
Frontiers Editorial Office Frontiers Editorial Office*

A Retraction of the Original Research Article
Mitofusin-2 enhances mitochondrial contact with the endoplasmic reticulum and promotes diabetic cardiomyopathy

by Zhang J, Zhang F and Wang Y (2021). Front. Physiol. 12:707634. doi: 10.3389/fphys.2021.707634

The Publisher retracts the cited article.

Following publication, the publisher uncovered evidence that false identities were used in the peer-review process. The assignment of fake reviewers was confirmed by an investigation, conducted in accordance with Frontiers’ policies and the Committee on Publication Ethics (COPE) guidelines.

The investigation also uncovered concerns about the presentation and validity of the data in the article that normally would have led to a rejection. When contacted, the authors failed to provide a data set that adequately supports the reported conclusions.

The authors have not responded to correspondence regarding this retraction.

This retraction was approved by the Chief Editors of Frontiers in Physiology and the Chief Executive Editor of Frontiers.

Citation: (2022) Retraction: Mitofusin-2 enhances mitochondrial contact with the endoplasmic reticulum and promotes diabetic cardiomyopathy. Front. Physiol. 13:1006583. doi: 10.3389/fphys.2022.1006583

Received: 29 July 2022; Accepted: 02 August 2022;
Published: 04 August 2022.

Approved by:

Geoffrey A. Head, Baker Heart and Diabetes Institute, Australia

Copyright © 2022 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Frontiers Editorial Office, editorial.office@frontiersin.org

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.